Molecular Express, Inc.

Ames, IA 50014

SBIR Award Summary

Total Number of Awards 17
Total Value of Awards $4.09MM
Active Awards 1 valued at $306K
First Award Date 09/15/01
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
Hamilton Richard T Hamilton 12 Message
Ilgu Muslum Ilgu 5

17 Awards Won

Phase 2 SBIR Active

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/17 - 08/31/18

? DESCRIPTION (provided by applicant): Acute kidney injury (AKI) affects more than 10 million people worldwide each year with reported mortalities from 15 to 60% in different patient populations. However, methods are lacking to support the early diagnosis of AKI that could lead to early intervention, improved therapy, better prognosis, and lo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/01/16 - 08/31/17

? DESCRIPTION (provided by applicant): Acute kidney injury (AKI) affects more than 10 million people worldwide each year with reported mortalities from 15 to 60% in different patient populations. However, methods are lacking to support the early diagnosis of AKI that could lead to early intervention, improved therapy, better prognosis, and lo...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 04/01/16 - 03/31/17

? DESCRIPTION (provided by applicant): Ebolavirus attacks are devastating and unpredictable. To control an ebolavirus outbreak it is essential to identify, isolate and treat infected individuas rapidly. However, the available diagnostics, ELISA and RT- PCR, require laboratory sophistication that is not possible at point-of-care in many African...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 09/14/15 - 08/31/16

DESCRIPTION (provided by applicant): Acute kidney injury (AKI) affects more than 10 million people worldwide each year with reported mortalities from 15 to 60% in different patient populations. However, methods are lacking to support the early diagnosis of AKI that could lead to early intervention, improved therapy, better prognosis, and lower m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 04/01/15 - 03/31/16

DESCRIPTION (provided by applicant): Ebolavirus attacks are devastating and unpredictable. To control an ebolavirus outbreak it is essential to identify, isolate and treat infected individuas rapidly. However, the available diagnostics, ELISA and RT- PCR, require laboratory sophistication that is not possible at point-of-care in many African and...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-12-088
Budget: 08/15/13 - 07/31/14

DESCRIPTION (provided by applicant): Acute kidney injury (AKI) affects more than 10 million people worldwide each year with reported mortalities from 15 to 60% in different patient populations. However, methods are lacking to support the early diagnosis of AKI that could lead to early intervention, improved therapy, better prognosis, and lower m...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-03-125
Budget: 09/01/09 - 08/31/12

DESCRIPTION (provided by applicant): Phase I The current proposal describes the selection of an aptamer that recognizes the drug PD173955, which is one of large family of substituted pyrido[2,3-d]pyrimidine inhibitors of tyrosine protein kinases. An aptamer is a single stranded nucleic acid that acts like an antibody but that can be expre...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-03-125
Budget: 09/01/08 - 08/31/09

DESCRIPTION (provided by applicant): Phase I The current proposal describes the selection of an aptamer that recognizes the drug PD173955, which is one of large family of substituted pyrido[2,3-d]pyrimidine inhibitors of tyrosine protein kinases. An aptamer is a single stranded nucleic acid that acts like an antibody but that can be expre...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-03-125
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): Phase I The current proposal describes the selection of an aptamer that recognizes the drug PD173955, which is one of large family of substituted pyrido[2,3-d]pyrimidine inhibitors of tyrosine protein kinases. An aptamer is a single stranded nucleic acid that acts like an antibody but that can be expre...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PAR-03-125
Budget: 09/01/06 - 08/31/07

DESCRIPTION (provided by applicant): Phase I The current proposal describes the selection of an aptamer that recognizes the drug PD173955, which is one of large family of substituted pyrido[2,3-d]pyrimidine inhibitors of tyrosine protein kinases. An aptamer is a single stranded nucleic acid that acts like an antibody but that can be expre...

Load More